These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15843562)

  • 1. Atorvastatin induces T cell anergy via phosphorylation of ERK1.
    Waiczies S; Prozorovski T; Infante-Duarte C; Hahner A; Aktas O; Ullrich O; Zipp F
    J Immunol; 2005 May; 174(9):5630-5. PubMed ID: 15843562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin suppresses inflammatory response induced by oxLDL through inhibition of ERK phosphorylation, IκBα degradation, and COX-2 expression in murine macrophages.
    Shao Q; Shen LH; Hu LH; Pu J; Jing Q; He B
    J Cell Biochem; 2012 Feb; 113(2):611-8. PubMed ID: 21956776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
    Fromigué O; Hamidouche Z; Marie PJ
    J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the ERK-1/2 signalling pathway results in alloantigen-specific anergy in human T cells.
    Krieger PM; Säemann MD; Böhmig GA; Mühlbacher F; Zlabinger GJ
    Transplant Proc; 2002 Aug; 34(5):1403-4. PubMed ID: 12176416
    [No Abstract]   [Full Text] [Related]  

  • 5. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of MAP kinases in atorvastatin-induced VEGF release in cardiac myocytes.
    Nakajima K; Suga H; Matsuno H; Ishisaki A; Hirade K; Kozawa O
    Life Sci; 2006 Aug; 79(12):1214-20. PubMed ID: 16701707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.
    Blank N; Schiller M; Krienke S; Busse F; Schätz B; Ho AD; Kalden JR; Lorenz HM
    J Immunol; 2007 Sep; 179(6):3613-21. PubMed ID: 17785796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
    Aktas O; Waiczies S; Smorodchenko A; Dorr J; Seeger B; Prozorovski T; Sallach S; Endres M; Brocke S; Nitsch R; Zipp F
    J Exp Med; 2003 Mar; 197(6):725-33. PubMed ID: 12629065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic role of atorvastatin in regulation of human retinal pigment epithelial cell behaviors in vitro.
    Wu WC; Lai YH; Hsieh MC; Chang YC; Wu MH; Wu HJ; Chang CW; Wu KY; Kao YH
    Exp Eye Res; 2011 Dec; 93(6):842-51. PubMed ID: 21989109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells.
    Wang D; Hirase T; Inoue T; Node K
    Biochem Biophys Res Commun; 2006 Aug; 347(2):394-400. PubMed ID: 16842760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
    Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.
    Leuenberger T; Pfueller CF; Luessi F; Bendix I; Paterka M; Prozorovski T; Treue D; Luenstedt S; Herz J; Siffrin V; Infante-Duarte C; Zipp F; Waiczies S
    PLoS One; 2014; 9(7):e100871. PubMed ID: 25013913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
    Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
    J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
    Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy.
    Crespi D; Massa S; Basso V; Colombetti S; Mueller DL; Mondino A
    Eur J Immunol; 2002 Sep; 32(9):2500-9. PubMed ID: 12207334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
    Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
    Mahajan N; Bahl A; Dhawan V
    Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin counteracts high glucose-induced Krüppel-like factor 2 suppression in human umbilical vein endothelial cells.
    Liu YS; Xu DL; Huang ZW; Hao L; Wang X; Lu QH
    Postgrad Med; 2015 Jun; 127(5):446-54. PubMed ID: 25927862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
    Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
    Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.